COVID-19 genome sequencing alliance formed with support from Birmingham

Investment of £20m has enabled the formation of a new nationwide consortium to map the spread and evolution of COVID-19 through whole-genome sequencing. The COVID-19 Genomics UK Consortium – COG-UK – comprised of the NHS, Public Health Agencies and academic institutions – including the University of Birmingham – will deliver large scale, rapid sequencing of … Continue reading “COVID-19 genome sequencing alliance formed with support from Birmingham”

COVID-19 research briefing 20/03/20

Researchers across BHP are collaborating to produce regular COVID-19 briefings based on the latest literature, in support of clinical colleagues. Led by Kylie Belchamber with colleagues from UHB and UoB (in particular the Birmingham Acute Care Research Group), these updates will be produced on around a weekly basis. Research Update – 20th March 2020 The … Continue reading “COVID-19 research briefing 20/03/20”

University makes hand sanitiser to support Birmingham’s frontline staff

Technicians and lab facilities at BHP founder member the University of Birmingham have been redeployed to respond to an urgent shortage of hand sanitiser needed by frontline social care workers to prevent the spread of the Coronavirus. At the request of Public Health England, a team of technicians are working at the University’s flagship Collaborative Teaching Laboratory … Continue reading “University makes hand sanitiser to support Birmingham’s frontline staff”

Shutting the door on COVID-19

By Professor Jason Mercer – Institute of Microbiology and Infection The path is clear: a proportion of the UK population will be infected by COVID-19. Echoing China and Italy, the vast majority of people infected will present with no or mild symptoms and recover quickly. Others, largely people over 60 years of age or those harboring … Continue reading “Shutting the door on COVID-19”

Antigens developed to aid fightback against coronavirus

The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain. These recombinant proteins offer scientists high-quality reagents to support ongoing infectious disease research, and … Continue reading “Antigens developed to aid fightback against coronavirus”